EUVIMEDEUVIMED entdecken
Editorial

From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease

Priya Vart

NEJM Evidence · 28.10.2025 · 4 (11)

DOI: 10.1056/evide2500255 ↗

Kurz gefasst

Editorial in der Zeitschrift NEJM Evidence, erschienen am 28.10.2025. Verfasst von Priya Vart. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Zitieren

APA

Vart, P. (2025). From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease. NEJM Evidence, 4(11). https://doi.org/10.1056/evide2500255

Vancouver

Vart P. From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease. NEJM Evidence. 2025;4(11). doi:10.1056/evide2500255

BibTeX
@article{Vart2025,
  author = {Vart, Priya},
  title = {From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease},
  journal = {NEJM Evidence},
  year = {2025},
  volume = {4},
  number = {11},
  doi = {10.1056/evide2500255}
}
Kostenlos starten →